Scientists use new technique to study the effects of reactive electrophilic drugs – News-Medical.net

In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple sclerosis, inflammation damages the protective myelin…

Click here to view the original article.